ロード中...
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval
The Food and Drug Administration (FDA) and European Medicines Agency (EMA) now have expedited review procedures for new drugs. We compared the review times of medicines licensed by the 2 agencies and explored differences in the evidence submitted. In 2015–2017 the FDA licensed 113 drugs, 66 of which...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6983504/ https://ncbi.nlm.nih.gov/pubmed/31657044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14130 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|